About OB/GYN - Aurora 2020
Here, at the office of Bernardita Druhan, DO, Sheila Roy, MD, Richard Tom, MD, and Rochelle Wilburn, MD, you’ll find thorough and experienced doctors who have a patient-centered approach. No question goes unanswered – and their personable style makes it easy to ask.
Whether you are adding to your family or need exceptional gynecologic care, you’ll find the healthcare providers you’ve been looking for.
We provide a broad range of services to meet the needs of women of all ages.
A sonohysterogram is a diagnostic procedure that does not require any anesthesia and is not considered a surgery. It is a technique in which your physician injects fluid into your uterus through a tube in your vaginal canal and then performs an ultrasound on your uterus. The fluid shows more detail of the inside of the uterus than when ultrasound is used alone, and is often ordered when a woman has had a normal ultrasound but is still having symptoms such as abnormal bleeding or infertility.
An ultrasound creates pictures of the internal organs of the body from sound waves. There is no radiation involved. Some ultrasounds are performed when a device is placed outside of the body, and some ultrasounds are performed by placing a transducer in the vaginal canal. These devices emit sound waves which then produce black and white images on a monitor. Ultrasounds are safe to have in pregnancy and are regularly used to examine the pelvic organs for problems.
At our office we offer a non-invasive prenatal test that looks for certain chromosome conditions in the baby. It requires only a blood draw and it is safe for mother and baby. This test is offered at the second visit between 11 1/2 - 13 1/2 weeks at the same time as the ultrasound done for nuchal translucency.
We also offer a hereditary cancer testing for hereditary breast and ovarian cancer. The test confirms the presence of a BRCA1 or BRCA2 gene mutation. BRCA mutations are responsible for the majority of hereditary breast and ovarian cancers. People with a mutation in either the BRCA1or BRCA2; gene have risks of up to 87% for developing breast cancer and up to 44% for developing ovarian cancer by age 70. Mutation carriers previously diagnosed with cancer also have a significantly increased risk of developing a second primary cancer. Genetic testing identifies patients who have these mutations.
- Menopause Management
- Prenatal Care
- Routine/Annual Exams
- Women's Health
- Gentle C-Section
- In-Office Ultrasound
- Robotic Assisted Surgery for Gynecological Procedures including Hysterectomy, Salpingectomy, Salpingo-oophorectomy, Cystectomy and Myomectomy